PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
By crossing the blood-brain barrier, DSIP acts at the core of neural and systemic balance, enabling a multidimensional therapeutic impact ( 8, 9 )
How to Calculate Your Sermorelin Dose Calculating your dose requires understanding the relationship between your vial concentration, syringe units, and desired mcg dose
See Sikiric et al., Curr Pharm Des, 2018 (PMID:30246642) for an overview of the reported mechanisms, and Chang et al., J Appl Physiol, 2011 (PMID:21030673) for a representative tendon-fibroblast study